Concentra Biosciences, LLC

Insider Reports History

Location
San Diego, CA
Signature
Kevin Tang, Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Concentra Biosciences, LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Jounce Therapeutics, Inc. 10%+ Owner Common Stock 36,367,727 $67,280,295 $1.85 03 May 2023 By LP
Jounce Therapeutics, Inc. 10%+ Owner Common Stock 10,000 $18,500 $1.85 03 May 2023 Direct

Insider Reports Filed by Concentra Biosciences, LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123027692-concentra-biosciences-llc-2023-05-03 Jounce Therapeutics, Inc. 03 May 2023 1 +$97,377,000 4 10%+ Owner 05 May 2023, 16:38
/report/000120919123027685-concentra-biosciences-llc-2023-05-03 Jounce Therapeutics, Inc. 03 May 2023 0 $0 3 10%+ Owner 05 May 2023, 16:35